Sagar Lonial - 11 Sep 2025 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
Director
Signature
/s/ Sagar Lonial
Issuer symbol
TGTX
Transactions as of
11 Sep 2025
Transactions value $
-$672,268
Form type
4
Filing time
12 Sep 2025, 16:42:45
Previous filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lonial Sagar Director 3020 CARRINGTON MILL BLVD, SUITE 475, MORRISVILLE /s/ Sagar Lonial 12 Sep 2025 0001816609

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX Common Stock Sale -$672K -20.9K -18.15% $32.24 94.1K 11 Sep 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the Company's restricted stock administrator in order to satisfy the Reporting Person's income tax obligations.
F2 Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $32.22 to $32.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes shares of restricted Common Stock, which vest over various time periods.